Diethylamine

Diethylamine

SCHEMBL635225

CCN(CC)C(O)=S.CCNCC.NC(O)=S

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CCKAR

The experimentally established mechanism targets of Diethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EHMT2 Q96KQ7 3/20 0.37
EHMT1 Q9H9B1 3/20 0.37
ABCB11 O95342 2/20 0.37
HTT P42858 2/20 0.37
GSDMD P57764 2/20 0.37
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA4 P22748 2/20 0.37
CA9 Q16790 2/20 0.37
CYP2E1 P05181 1/20 0.37
PTGS1 P23219 1/20 0.37
TP53 P04637 2/20 0.36
ALDH1A1 P00352 3/20 0.36
ALDH2 P05091 3/20 0.36
PHGDH O43175 3/20 0.36
MGLL Q99685 3/20 0.36
CYP3A4 P08684 2/20 0.36
ALOX15 P16050 2/20 0.36
PLIN1 O60240 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diethylamine SCHEMBL8672659 0.93 TP53 (0.42) EHMT2EHMT1ABCB11HTTGSDMD
SCHEMBL48383 0.88 CA12 (0.46) EHMT2EHMT1ABCB11HTTGSDMD
SCHEMBL213880 0.85 CA12 (0.43) EHMT2EHMT1ABCB11HTTGSDMD
Hydrochloric Acid SCHEMBL21359740 0.85 CA12 (0.43) EHMT2EHMT1ABCB11HTTGSDMD
SCHEMBL1882185 0.85 CA12 (0.43) EHMT2EHMT1ABCB11HTTGSDMD
SCHEMBL25284943 0.85 CA12 (0.43) EHMT2EHMT1ABCB11HTTGSDMD
SCHEMBL1887058 0.85 CA12 (0.43) EHMT2EHMT1ABCB11HTTGSDMD
SCHEMBL11148937 0.85 CA12 (0.43) EHMT2EHMT1ABCB11HTTGSDMD
SCHEMBL43744 0.85 CA12 (0.43) EHMT2EHMT1ABCB11HTTGSDMD
SCHEMBL8968072 0.85 CA12 (0.43) EHMT2EHMT1ABCB11HTTGSDMD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117659056-A Holmium complex luminescent material and preparation method and application thereof 北京石油化工学院 2024-03-08 CN claimed
CN-115429780-A Use of disulfiram for protecting gastrointestinal tissue against damage caused by ionizing radiation 中国人民解放军军事科学院军事医学研究院 2022-12-06 CN claimed
CN-102179066-B Method for extracting and separating ions in two valence states of the same element in three phases INST PROCESS ENG CAS 2013-10-16 CN claimed
CN-102179066-A Method for extracting and separating ions in two valence states of the same element in three phases INST PROCESS ENG CAS 2011-09-14 CN claimed
CN-101445699-B High temperature resistant powder coating DUBANG HUAJIA CHEMICAL CO LTD 2011-05-25 CN claimed
CN-101445699-A High temperature resistant powder coating DUBANG HUAJIA CHEMICAL CO LTD (CN) 2009-06-03 CN claimed
US-4803051-A METAL ANALYSIS USING ADSORBED VOLATILE METAL COMPLEXES FORMED FROM REAGENT AND SAMPLE BODENSEEWERK PERKIN-ELMER & CO., GMBH (DE) 1989-02-07 US claimed
JP-3141118-A None JP disclosed
US-12567515-B2 Conductive film, touch panel, photosensitive resin composition, and method of manufacturing conductive film FUJIFILM CORPORATION (JP) 2026-03-03 US disclosed
US-12515253-B2 Compositions, comprising silver nanoplatelets BASF SE (DE) 2026-01-06 US disclosed
US-12410144-B2 Triazinane derivatives and methods of making them FLEXSYS AMERICA L.P. (US) 2025-09-09 US disclosed
US-20250160193-A1 CONJUGATED POLYMERS AS HOLE TRANSPORT MATERIALS FOR ENHANCED THERMAL STABILITY IN OPTOELECTRONIC DEVICES U. S. DEPARTMENT OF ENERGY 2025-05-15 US disclosed
US-12208447-B2 Compositions, comprising silver nanoplatelets BASF SE (DE) 2025-01-28 US disclosed
US-4636245-A Herbicidal tetrahydrothiopyran-2,4-dione derivatives, compositions, and method of use therefor BAYER AKTIENGESELLSCHAFT (DE) 1987-01-13 US disclosed
US-4585628-A OXIDATION, COM-LEXING, SOLVENT EXTRACTION AMERICAN CYANAMID COMPANY (US) 1986-04-29 US disclosed
US-4547554-A After-chlorinated ethylene/butene-1 copolymer and process for its production OSAKA SODA CO., LTD. (JP) 1985-10-15 US disclosed
US-4148795-A Dithiocarbamate ester bactericides and fungicides AMERICAN CYANAMID COMPANY (US) 1979-04-10 US disclosed
US-4038288-A DITHIOCARBAMATE ESTER BACTERICIDES AND FUNGICIDES AMERICAN CYANAMID COMPANY (US) 1977-07-26 US disclosed
US-4036650-A SILVER SALT, SILVER HALIDE, REDUCING AGENT CANON KABUSHIKI KAISHA (JA) 1977-07-19 US disclosed
US-4011230-A DITHIOCARBAMATE ESTER BACTERICIDES AND FUNGICIDES AMERICAN CYANAMID COMPANY (US) 1977-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12410144-B2 Triazinane derivatives and methods of making them CBR3, CBR1, HDAC3 EHMT2 1033/4885EHMT1 1340/4885ABCB11 2331/4885
US-12567515-B2 Conductive film, touch panel, photosensitive resin composition, and method of manufacturing conductive film TAS1R2, TAS1R3, TAS1R1 EHMT2 1165/4885EHMT1 1235/4885ABCB11 4469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.